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Abstract
Background
The effectiveness of screening for macrosomia is not well established. One of the critical
elements of an effective screening program is the diagnostic accuracy of a test at predicting
the condition. The objective of this study is to investigate the diagnostic effectiveness of uni-
versal ultrasonic fetal biometry in predicting the delivery of a macrosomic infant, shoulder
dystocia, and associated neonatal morbidity in low- and mixed-risk populations.
Methods and findings
We conducted a predefined literature search in Medline, Excerpta Medica database
(EMBASE), the Cochrane library and ClinicalTrials.gov from inception to May 2020. No lan-
guage restrictions were applied. We included studies where the ultrasound was performed
as part of universal screening and those that included low- and mixed-risk pregnancies and
excluded studies confined to high risk pregnancies. We used the estimated fetal weight
(EFW) (multiple formulas and thresholds) and the abdominal circumference (AC) to define
suspected large for gestational age (LGA). Adverse perinatal outcomes included macroso-
mia (multiple thresholds), shoulder dystocia, and other markers of neonatal morbidity. The
risk of bias was assessed using the Quality Assessment of Diagnostic Accuracy Studies
(QUADAS-2) tool. Meta-analysis was carried out using the hierarchical summary receiver
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operating characteristic (ROC) and the bivariate logit-normal (Reitsma) models. We identi-
fied 41 studies that met our inclusion criteria involving 112,034 patients in total. These
included 11 prospective cohort studies (N = 9986), one randomized controlled trial (RCT)
(N = 367), and 29 retrospective cohort studies (N = 101,681). The quality of the studies was
variable, and only three studies blinded the ultrasound findings to the clinicians. Both EFW
>4,000 g (or 90th centile for the gestational age) and AC >36 cm (or 90th centile) had >50%
sensitivity for predicting macrosomia (birthweight above 4,000 g or 90th centile) at birth with
positive likelihood ratios (LRs) of 8.74 (95% confidence interval [CI] 6.84–11.17) and 7.56
(95% CI 5.85–9.77), respectively. There was significant heterogeneity at predicting macro-
somia, which could reflect the different study designs, the characteristics of the included
populations, and differences in the formulas used. An EFW >4,000 g (or 90th centile) had
22% sensitivity at predicting shoulder dystocia with a positive likelihood ratio of 2.12 (95%
CI 1.34–3.35). There was insufficient data to analyze other markers of neonatal morbidity.
Conclusions
In this study, we found that suspected LGA is strongly predictive of the risk of delivering a
large infant in low- and mixed-risk populations. However, it is only weakly (albeit statistically
significantly) predictive of the risk of shoulder dystocia. There was insufficient data to ana-
lyze other markers of neonatal morbidity.
Author summary
Why was this study done?
• There is a debate regarding introducing universal third-trimester screening for macro-
somia. An effective screening program requires two elements: an effective test at pre-
dicting a condition and an effective intervention.
• There is evidence that early-term induction of labor (IOL) could reduce the rates of
shoulder dystocia. However, there is no high-quality evidence regarding the diagnostic
effectiveness of fetal biometry at predicting macrosomia and associated morbidity.
What did the researchers do and find?
• We searched more than 10,000 titles and identified 41 studies including 112,034 patients
that offered third-trimester ultrasounds for the prediction of macrosomia as part of uni-
versal ultrasound screening or were done in low- and mixed-risk populations. The qual-
ity of the studies was variable, and only three studies blinded the ultrasound findings to
the clinicians.
• We found that the two most common ultrasound markers, the estimated fetal weight
(EFW) and the abdominal circumference (AC), could predict the majority of macroso-
mic infants at birth (sensitivity >50%) with high diagnostic performance (positive LRs
between 7 and 10).
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• However, the EFW could only predict about 1 in 5 cases of shoulder dystocia (22% sen-
sitivity) with low diagnostic performance (positive likelihood ratio of about 2). There
was insufficient data to analyze other markers of neonatal morbidity.
What do these findings mean?
• Universal third-trimester ultrasound screening will identify more pregnancies with
macrosomia. However, it will not have a clinically significant effect at predicting shoul-
der dystocia. There is not enough evidence on the effect of ultrasound screening on neo-
natal morbidity.
• We recommend caution prior to introducing universal third-trimester screening for
macrosomia, as it would increase the rates of intervention, with potential iatrogenic
harm, without clear evidence that it would reduce neonatal morbidity.
Introduction
Macrosomia is usually defined as birthweight>4,000 g or>90th centile for sex and gestational
age. Macrosomic birth weight is associated with the risk of adverse outcomes, including perinatal
death [1] and injuries related to traumatic delivery [2]. Ultrasonic estimated fetal weight (EFW)
was first described in 1975 [3]. The equation for EFW that is in most widespread use was pub-
lished by Hadlock and colleagues in 1985 [4], and the distribution of EFW in relation to week of
gestation was published in 1991 [5]. Hence, the diagnostic tools to identify small for gestational
age (SGA) and large for gestational age (LGA) fetuses have been available for many years. One of
the main complications associated with macrosomia is shoulder dystocia, and a Cochrane review
of four randomized controlled trials (RCTs) including 1,190 women demonstrated that routine
induction of labor (IOL) for suspected LGA may prevent this outcome [6]. However, it remains
unclear whether screening and intervention for suspected LGA results in better outcomes.
An RCT of IOL in women with an ultrasonically suspected LGA infant is in progress in the
United Kingdom (The Big Baby trial, ISRCTN18229892). However, the women recruited to
this trial will have been scanned because they were high risk for some reason, as the National
Institute for Health and Care Excellence (NICE) has recommended that women should not be
routinely scanned in late pregnancy [7]. Although the trial will confirm whether IOL is effec-
tive in high-risk women, it will not determine whether screening women without risk factors
and intervening results in net benefit. It is often the case that screening and intervention pro-
grams that work well in high-risk groups do not work as well in low-risk populations, and one
explanation for this can be that the screening test is less informative in low- and mixed-risk
populations due to the lower prior risk of disease. In this study, we sought to quantify the diag-
nostic effectiveness of screening for fetal macrosomia and associated complications using uni-
versal ultrasonic fetal biometry in late pregnancy.
Methods
Sources
The protocol for this review was prospectively written and registered with PROSPERO (the
International Prospective Register of Systematic Reviews), and the registration number was
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CRD42017064093. We searched the literature systematically using the Cochrane Database of
Systematic Reviews (CDSR), Cochrane Central Register of Controlled Trials (CENTRAL),
Medline, EMBASE, and ClinicalTrials.gov from inception to August 2019. An update search
was done on May 28, 2020. We applied no restrictions on the language of the report or the
location of the study. The studies were identified using a combination of words related to
“ultrasound,” “pregnancy,” “estimated fetal weight,” “EFW,” “birthweight,” “macrosomia,”
“large for gestational age,” “shoulder dystocia,” and “brachial plexus injury.” The exact search
strategy is presented in S1 Text.
Study selection
We set out to include cohort studies where an ultrasound scan was performed�24 weeks’ ges-
tation (wkGA), excluding multiple pregnancies. We included studies of low-risk populations,
universal screening, and mixed-risk populations (i.e., included both high-risk and low-risk
pregnancies). Studies that included only high-risk women, such as patients with preexisting or
gestational diabetes, and those in which the ultrasound was performed during labor were
excluded. Studies were not selected on the basis of the definition of the index test, i.e., the for-
mula and the threshold used. Finally, we included both blinded and unblinded studies.
Index tests and outcomes
For the purposes of the meta-analysis, we defined suspected LGA as a fetus with an EFW
>4,000 g or>90th centile or with an abdominal circumference (AC)>36 cm or>90th centile.
However, we have also documented other thresholds used. The outcomes studied included
macrosomic birth weight (>4,000 g or >90th centile) and severe macrosomic birth weight
(>4,500 g or >97th centile); shoulder dystocia; and perinatal morbidity (neonatal unit admis-
sion, 5-minute Apgar score of six or less, metabolic acidosis, neonatal hypoglycaemia, and neo-
natal jaundice).
Quality assessment
Two authors (AAM and NS) independently performed the literature search, using the software
package Review Manager 5.3. Any differences were addressed in consultation with the senior
author (GCS). The Quality Assessment of Diagnostic Accuracy Studies (QUADAS 2) tool was
used to assess the risk of biases, following the Cochrane Handbook of Diagnostic Test Accuracy
Studies [8]. The QUADAS 2 tool was employed to assess potential biases in patient selection,
index test, reference standard, and flow and timing. In relation to flow and timing, we assessed
the risk from the perspective of universal ultrasound screening near term (i.e., around 36
wkGA). Flow and timing are based on the timing of the ultrasound scan, the timing of delivery,
and the length of the interval between scan and delivery. A standardized data extraction form
was employed to obtain information on the characteristics of the study (publication year,
location, setting, study design, blinding), the participants (inclusion and exclusion rules and
number, including inclusion or exclusion of women with diabetes, either preexisting or gesta-
tional), the index test (range of wkGA when the scan was conducted, the EFW equation
employed, and the threshold for screen positive), reference standard (outcome, wkGA at deliv-
ery, and the scan-to-delivery interval).
Data extraction and synthesis
Sensitivity, specificity, positive and negative likelihood ratios (LRs) [9] were calculated from
standard two-by-two tables, which had been extracted for each study by tabulating each of the
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different definitions of screen positive with each of the different outcomes studied. The
“hierarchical summary receiver–operating characteristics” (HSROC) model of Rutter and
Gatsonis [10] was utilized for data synthesis. This method allows the results of studies to be
combined despite variation between studies in the threshold employed for screen positive.
The bivariate logit-normal (Reitsma) model [11] was used to calculate average estimates of
sensitivity and specificity and respective variances, at a specific threshold, in analyses in
which data were available from at least four studies. We also used meta-analysis to obtain a
summary of the diagnostic odds ratios (DORs) [12]. Publication bias was assessed using the
Deeks’ funnel plot asymmetry test when data was available from a sufficient number of stud-
ies. Significant asymmetry was assumed at P< 0.05 [13]. Statistical analyses were performed
using STATA version 14 (StataCorp LP, College Station, Texas), specifically, its METANDI,
METAN, and MIDAS packages. Analysis and reporting was performed using the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (S1
PRISMA Checklist) [14].
Results
Study characteristics
Fig 1 is the literature search PRISMA flowchart. Out of 9,811 unique titles and 72 full paper
reviews, we identified 41 studies [15–55] fulfilling the inclusion criteria, including a total of
112,034 participants. The study characteristics are presented in S1 Table. Six studies [18,27,33,
36,37,52] (N = 53,935) included unselected pregnancies, nine [23,29,31–33,35,43,45,53,54]
(N = 6,436) were confined to low-risk pregnancies, and 26 [15–17, 9–22,24–26,28,30,34,38–
42,44,46–51,55] (N = 51,663) recruited pregnancies at mixed risk. The list of the excluded stud-
ies and the reasons for the exclusion are presented in S2 Table.
Quality assessment
The risk of bias, as assessed by the QUADAS-2 tool, is summarized in Fig 2 and presented in
detail in S1 Fig. The Galvin 2017 study [29] was published as an abstract; hence, we used a dif-
ferent study from the same cohort (GENESIS study) [56] to assess the risk of bias. Two of the
included studies [51,52] have been authored by some of the coauthors of this paper. We used
the same criteria for the quality assessment and analysis. Only three studies—Sovio 2018 [52]
(Pregnancy Outcome Prediction study), Galvin 2017 [29] (GENESIS study), and Peregrine
2007 [47]—blinded the results to the clinicians. Hence, the large majority of studies were at
risk of bias in relation to the reference standard. The second most common risk of bias was in
relation to flow and timing, as six studies [19,24,36,39,47,55] performed the ultrasound either
prior to IOL or less than 72 hours before delivery, resulting in a very short interval between the
scan and delivery. Conversely, two studies [18,27] had a very long interval (ultrasound <33
wkGA). Two studies [17,20] did not present data on the gestational age at delivery. Finally,
three studies [23,48,54] were confined to pregnancies progressing beyond 41 wkGA and were
classified as having “high applicability concerns due to patient selection”.
Meta-analysis results
Full details of the summary diagnostic performance are presented in Table 1. In summary,
both definitions of ultrasonically suspected macrosomia (i.e., either EFW >4,000 g or>90th
percentile) had >50% sensitivity for predicting LGA at birth. Many associations were similar
regardless of the formula employed, but the positive LRs for the Hadlock formulae (ranging
between 7.5 and 12) tended to be higher than for the Shepard formula (around 5). The
PLOS MEDICINE Third-trimester screening for macrosomia
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Fig 1. PRISMA flow diagram.
https://doi.org/10.1371/journal.pmed.1003190.g001
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Fig 2. Summary of bias assessment using the QUADAS-2 tool of the studies included in the meta-analysis. QUADAS 2, Quality Assessment of Diagnostic Accuracy
Studies.
https://doi.org/10.1371/journal.pmed.1003190.g002
Table 1. Summary diagnostic performance of suspected LGA to predict adverse perinatal outcome.
Diagnostic test Studies Patients Summary sensitivity Summary specificity Positive LR
(95% CI)
Negative LR
(95% CI)
(95% CI) (95% CI)
Outcome: Birthweight >4,000 g (or 90th centile)
EFW (any) >4,000 g (or 90th centile) 30 80,045 53.2% 93.9% 8.74 0.50
(47.2%–59.1%) (91.9%–95.5%) (6.84–11.17) (0.44–0.56)
EFW (Hadlock-AC/FL/HC/BPD) 9 22,073 63.1% 94.3% 11.13 0.39
(49.1%–75.2%) (90.9%–96.5%) (8.24–15.04) (0.28–0.55)
EFW (Hadlock- AC/FL/BPD) 10 17,110 55.1% 92.9% 7.77 0.48
(44.1%–65.7%) (89.7%–95.2%) (5.55–10.89) (0.38–0.61)
EFW (Hadlock- AC/FL/HC) 7 60,648 55.2% 94.9% 11.84 0.47
(45.7%–64.2%) (92.4%–96.6%) (7.46–15.74) (0.39–0.58)
EFW (Hadlock- AC/FL) 9 16,736 60.5% 92.0% 7.54 0.43
(50.7%–69.5%) (89.4%–93.7%) (6.13–9.29) (0.34–0.54)
EFW (Hadlock- AC/BPD) 6 13,617 62.9% 93.7% 9.99 0.40
(36.1%–83.5%) (85.9%–97.3%) (6.40–15.58) (0.21–0.75)
EFW (Shepard) 7 14,060 73.7% 85.1% 4.96 0.31
(54.4%–86.9%) (76.5%–90.9%) (3.29–7.48) (0.17–0.56)
AC >36cm (or 90th centile) 5 10,543 57.8% 92.3% 7.56 0.46
(39.6%–74.2%) (88.7%–94.9%) (5.85–9.77) (0.30–0.68)
Outcome: Birthweight >4,500 g (or 97th centile)
EFW (any) >4,000 g (or 90th centile) 5 51,686 67.5% 89.7% 6.58 0.36
(47.8%–82.6%) (79.1%–95.3%) (2.78–15.58) (0.20–0.65)
Outcome: Shoulder dystocia
EFW (any) >4,000 g (or 90th centile) 6 26,264 22.0% 89.6% 2.12 0.87
(9.9%–42.0%) (80.8%–94.6%) (1.34–3.35) (0.74–1.02)
Abbreviations: AC, abdominal circumference; BPD, Biparietal diameter; CI, confidence interval; EFW, estimated fetal weight; FL, femur length; HC, head
circumference; LR, likelihood ratio
https://doi.org/10.1371/journal.pmed.1003190.t001
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performance of definitions using just the AC was similar to using an ultrasonic EFW. The sen-
sitivity for predicting severe macrosomia at birth of suspected LGA was around 70%. However,
macrosomia (EFW>4,000 g or >90th centile) had a lower (22%) sensitivity for predicting
shoulder dystocia, although the association was statistically significant and the positive LR was
approximately 2.
Fig 3 has summary ROC curves for shoulder dystocia and macrosomia. For the prediction
of macrosomia at birth, most of the large studies were close to the point estimate, and only a
few small studies were outside the prediction intervals. For shoulder dystocia, most studies
reported sensitivities below 30%, and only one study [55] reported a sensitivity of>50%. How-
ever, in this study, the total number of shoulder dystocia cases was very small (n = 3). Fig 4 and
Fig 5 present graphs of the pooling of DORs for macrosomia and shoulder dystocia, respec-
tively. There was significant heterogeneity for the prediction of macrosomia but not for the
prediction of shoulder dystocia.
Only three studies—Crimmins 2018 [25], Galvin 2017 [29], and Sovio 2018 [52]—reported
neonatal unit admission as an outcome, and a meta-analysis was not feasible. However, none
of the studies reported statistically significant results with positive LRs of 0.73 (95% confidence
interval [CI] 0.36–1.48), 1.39 (95% CI 0.97–2.00), and 1.33 (95% CI 0.80–2.22), respectively.
Only the Sovio 2018 [52] study reported on 5-minute Apgar score of less than 7 and neonatal
metabolic acidosis with positive LRs of 1.94 (95% CI 0.66–5.75) and 1.08 (95% CI 0.28–4.18),
respectively. Moreover, the Sovio 2018 study was the only one that reported on neonatal hypo-
glycaemia and neonatal jaundice with positive LRs of 1.9 (95% CI 1.1–3.4) and 1.2 (95% CI
0.6–2.4), respectively.
The analysis demonstrated no significant evidence of publication bias (P = 0.57) when eval-
uated using Deeks’ funnel plot asymmetry test (S2 Fig).
Fig 3. Summary ROC curves for the diagnostic performance of EFW>4,000 g (or 90th centile) at predicting (A) macrosomia at birth (birthweight above 4,000 g or
above the 90th centile) and (B) shoulder dystocia. EFW, estimated fetal weight.
https://doi.org/10.1371/journal.pmed.1003190.g003
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Discussion
The main conclusion of this analysis is that an ultrasonic EFW indicating an increased risk of
a large baby was strongly associated with delivering a macrosomic infant, but it was only
weakly associated with the risk of shoulder dystocia. When the EFW was calculated using the
widely employed Hadlock method, the positive LRs for macrosomia were in the region of 7 to
12, whereas they were approximately 2 in relation to the risk of shoulder dystocia.
Fig 4. Diagnostic performance of EFW>4,000 g (or 90th centile) at predicting macrosomia at birth (birthweight above 4,000 g or above the 90th centile). EFW,
estimated fetal weight.
https://doi.org/10.1371/journal.pmed.1003190.g004
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This is the largest systematic review on the prediction of macrosomia and the only study
that was focused on low- and mixed-risk populations from the perspective of using third-tri-
mester ultrasound as routine screening in all pregnancies. We reported on multiple ultrasound
markers and formulas. Moreover, we also reported on the prediction of shoulder dystocia,
which is a major perinatal complication, the prevention of which would be a major aim of the
routine ultrasound screening. The main limitation of this study is that there was significant
heterogeneity between the studies in the ability to predict a macrosomic infant, as the forest
plot of DORs indicates. The source of this heterogeneity is unclear, but it could relate to differ-
ences in the quality of the performance of the diagnostic test, such as the quality of the imaging
equipment, the skill and training of sonographers, and the characteristics of the population.
Finally, despite the large amount of studies included, only three studies [25, 29, 52] reported
any outcomes of neonatal morbidity, and a meta-analysis was not feasible.
In the current study, we incorporated previously published data from the POP study (Sovio
2018) [52], which included nulliparous women who had a research scan at 36 wkGA, which was
blinded in most cases to the clinicians. We found that the DOR (95% CI) from the POP study was
very similar to the summary DOR derived from all of the other studies, which suggests that the
results from the POP study are likely to be generalizable. The POP study was one of only a few
identified that blinded the ultrasound result. Another blinded study, conducted in seven centers
across Ireland between 2012 and 2015, the GENESIS study (Galvin 2017) [29], was a prospective
cohort study of 2,772 nulliparous pregnant women. The results of the GENESIS study have only
Fig 5. Diagnostic performance of EFW>4,000 g (or 90th centile) at predicting shoulder dystocia. EFW, estimated fetal weight.
https://doi.org/10.1371/journal.pmed.1003190.g005
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been published in conference proceedings [29] and include the outcome of shoulder dystocia but
not macrosomia. Interestingly, neither the POP study nor the GENESIS study observed a statisti-
cally significant association between ultrasonic LGA and shoulder dystocia. When blinded and
unblinded studies were combined, the meta-analysis demonstrated that ultrasound may be pre-
dictive of shoulder dystocia, albeit weakly. However, the associations observed in the other studies
may be due to ascertainment bias. Specifically, if the fetus is suspected to be large on the basis of
the EFW, the staff attending the delivery may have a lower threshold for using maneuvers for
shoulder dystocia in the event of any delay. They may also be more likely to document a given
delay as being due to shoulder dystocia. Hence, unblinded studies could result in stronger associa-
tions with shoulder dystocia through ascertainment bias. The fact that ultrasonic EFW is relatively
poor as a predictor of shoulder dystocia is not unexpected, given that the actual birth weight of
the baby is also not strongly predictive of the outcome: the majority of cases of shoulder dystocia
involve a normal birth weight infant [57].
Finally, ultrasonic suspicion of a large baby is a clinical situation where there is evidence
that knowledge of the scan result may itself cause complications. Multiple studies have demon-
strated that women who have a false positive diagnosis of fetal macrosomia based on EFW are
more likely to be delivered by emergency caesarean section [58,59]. This finding underlines
the potential for harm caused by screening low-risk women. Research studies in which the
results of the scan are revealed could lead to associations with adverse outcomes that were
caused by an iatrogenic harm from a false positive result. Conversely, analysis of studies in
which the scan was revealed may fail to show true associations with adverse outcome as knowl-
edge of the scan result led to interventions that mitigated the risk.
We conclude that ultrasonically suspected LGA in the general population has quite good
diagnostic effectiveness for macrosomic birth weight. However, it is not strongly predictive of
the risk of associated complications, such as shoulder dystocia. Similar observations have been
made in relation to ultrasonically suspected SGA [60, 61]. That study indicated that reduced
fetal abdominal growth velocity helped discriminate between healthy SGA babies and those
that were at increased risk of complications. Interestingly, the analogous finding is also true in
LGA babies, in whom the combination of LGA and accelerated abdominal growth velocity
was associated with the risk of neonatal morbidity [52]. We believe that future studies should
address the other factors which help differentiate those suspected LGA fetuses which are at the
greatest risk of complications.
Supporting information
S1 PRISMA Checklist. PRISMA checklist.
(DOC)
S1 Text. Literature search strategy for Medline and EMBASE (from inception to May
2020).
(DOCX)
S1 Table. Characteristics of the studies included in the meta-analysis.
(DOCX)
S2 Table. List of studies excluded from the meta-analysis and reason for exclusion.
(DOCX)
S1 Fig. Risk of bias assessment using the QUADAS 2 tool. QUADAS 2, Quality Assessment
of Diagnostic Accuracy Studies
(TIFF)
PLOS MEDICINE Third-trimester screening for macrosomia
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003190 October 13, 2020 11 / 15
S2 Fig. Deeks’ funnel plot asymmetry test.
(TIFF)
Acknowledgments
The views expressed here are those of the authors and not necessarily those of the NHS, the
NIHR, or the Department of Health.
Author Contributions
Conceptualization: Alexandros A. Moraitis, Peter Brocklehurst, Alexander E. P. Heazell, Jim
G. Thornton, Stephen C. Robson, Aris Papageorghiou, Gordon C. Smith.
Data curation: Alexandros A. Moraitis, Norman Shreeve, Ulla Sovio.
Formal analysis: Alexandros A. Moraitis, Norman Shreeve, Ulla Sovio, Gordon C. Smith.
Funding acquisition: Peter Brocklehurst, Jim G. Thornton, Stephen C. Robson, Aris Papa-
georghiou, Gordon C. Smith.
Investigation: Alexandros A. Moraitis.
Methodology: Alexandros A. Moraitis, Ulla Sovio, Peter Brocklehurst, Gordon C. Smith.
Supervision: Gordon C. Smith.
Visualization: Alexandros A. Moraitis.
Writing – original draft: Alexandros A. Moraitis, Gordon C. Smith.
Writing – review & editing: Alexandros A. Moraitis, Norman Shreeve, Ulla Sovio, Peter
Brocklehurst, Alexander E. P. Heazell, Jim G. Thornton, Stephen C. Robson, Aris Papageor-
ghiou, Gordon C. Smith.
References
1. Moraitis AA, Wood AM, Fleming M, Smith GC. Birth weight percentile and the risk of term perinatal
death. Obstetrics and gynecology. 2014; 124(2 Pt 1):274–83. Epub 2014/07/09. doi: 10.1097/aog.
0000000000000388. PMID: 25004344.
2. Esakoff TF, Cheng YW, Sparks TN, Caughey AB. The association between birthweight 4000 g or
greater and perinatal outcomes in patients with and without gestational diabetes mellitus. American
journal of obstetrics and gynecology. 2009; 200(6):672.e1–4. Epub 2009/04/21. doi: 10.1016/j.ajog.
2009.02.035. PMID: 19376489.
3. Campbell S, Wilkin D. Ultrasonic measurement of fetal abdomen circumference in the estimation of
fetal weight. British journal of obstetrics and gynaecology. 1975; 82(9):689–97. Epub 1975/09/01. doi:
10.1111/j.1471-0528.1975.tb00708.x. PMID: 1101942.
4. Hadlock FP, Harrist RB, Sharman RS, Deter RL, Park SK. Estimation of fetal weight with the use of
head, body, and femur measurements—a prospective study. American journal of obstetrics and gyne-
cology. 1985; 151(3):333–7. Epub 1985/02/01. https://doi.org/10.1016/0002-9378(85)90298-4 PMID:
3881966.
5. Hadlock FP, Harrist RB, Martinez-Poyer J. In utero analysis of fetal growth: a sonographic weight stan-
dard. Radiology. 1991; 181(1):129–33. Epub 1991/10/01. doi: 10.1148/radiology.181.1.1887021.
PMID: 1887021.
6. Boulvain M, Irion O, Dowswell T, Thornton JG. Induction of labour at or near term for suspected fetal
macrosomia. Cochrane Database Syst Rev. 2016;(5):Cd000938. Epub 2016/05/23. doi: 10.1002/
14651858.CD000938.pub2. PMID: 27208913.
7. National Collaborating Centre for Ws, Children’s H. National Institute for Health and Clinical Excellence:
Guidance. Antenatal Care: Routine Care for the Healthy Pregnant Woman. London: RCOG Press
National Collaborating Centre for Women’s and Children’s Health.; 2008.
PLOS MEDICINE Third-trimester screening for macrosomia
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003190 October 13, 2020 12 / 15
8. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised
tool for the quality assessment of diagnostic accuracy studies. Annals of internal medicine. 2011; 155
(8):529–36. Epub 2011/10/19. doi: 10.7326/0003-4819-155-8-201110180-00009. PMID: 22007046.
9. Simel DL, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diag-
nostic test studies. J Clin Epidemiol. 1991; 44(8):763–70. Epub 1991/01/01. https://doi.org/10.1016/
0895-4356(91)90128-v PMID: 1941027.
10. Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accu-
racy evaluations. Statistics in medicine. 2001; 20(19):2865–84. Epub 2001/09/25. https://doi.org/10.
1002/sim.942 PMID: 11568945.
11. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sen-
sitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol.
2005; 58(10):982–90. Epub 2005/09/20. doi: 10.1016/j.jclinepi.2005.02.022. PMID: 16168343.
12. Deeks JJ. Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and
screening tests. BMJ (Clinical research ed). 2001; 323(7305):157–62. Epub 2001/07/21. https://doi.org/
10.1136/bmj.323.7305.157 PMID: 11463691; PubMed Central PMCID: PMC1120791.
13. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size
effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005; 58
(9):882–93. Epub 2005/08/09. doi: 10.1016/j.jclinepi.2005.01.016. PMID: 16085191.
14. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-
analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. Epub 2009/07/22. doi: 10.1371/
journal.pmed.1000097. PMID: 19621072; PubMed Central PMCID: PMC2707599.
15. Aviram A, Yogev Y, Ashwal E, Hiersch L, Hadar E, Gabbay-Benziv R. Prediction of large for gestational
age by various sonographic fetal weight estimation formulas-which should we use? Journal of Perinatol-
ogy. 2017; 37(5):513–7. https://doi.org/10.1038/jp.2017.5 PMID: 28151496.
16. Balsyte D, Schaffer L, Burkhardt T, Wisser J, Kurmanavicius J. Sonographic prediction of macrosomia
cannot be improved by combination with pregnancy-specific characteristics. Ultrasound in Obstetrics &
Gynecology. 2009; 33(4):453–8. https://doi.org/10.1002/uog.6282 PMID: 19266500.
17. Benacerraf BR, Gelman R, Frigoletto FD Jr. Sonographically estimated fetal weight: Accuracy and limi-
tation. American Journal of Obstetrics and Gynecology. 1988; 159(5):1118–21. https://doi.org/10.1016/
0002-9378(88)90425-5 PMID: 3055999.
18. Ben-Haroush A, Yogev Y, Hod M, Bar J. Predictive value of a single early fetal weight estimate in normal
pregnancies. European Journal of Obstetrics Gynecology and Reproductive Biology. 2007; 130
(2):187–92. PMID: 46097242.
19. Ben-Haroush A, Melamed N, Mashiach R, Meizner I, Yogev Y. Use of the amniotic fluid index combined
with estimated fetal weight within 10 days of delivery for prediction of macrosomia at birth. Journal of
Ultrasound in Medicine. 2008; 27(7):1029–32. https://doi.org/10.7863/jum.2008.27.7.1029 PMID:
18577666.
20. Benson CB, Coughlin BF, Doubilet PM. Amniotic fluid volume in large-for-gestational-age fetuses of
nondiabetic mothers. Journal of Ultrasound in Medicine. 1991; 10(3):149–51. https://doi.org/10.7863/
jum.1991.10.3.149 PMID: 2027186.
21. Burkhardt T, Schmidt M, Kurmanavicius J, Zimmermann R, Schaffer L. Evaluation of fetal anthropomet-
ric measures to predict the risk for shoulder dystocia. Ultrasound in obstetrics & gynecology: the official
journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2014; 43(1):77–82.
PMID: 373970964.
22. Chauhan SP, Parker D, Shields D, Sanderson M, Cole JH, Scardo JA. Sonographic estimate of birth
weight among high-risk patients: feasibility and factors influencing accuracy. American journal of obstet-
rics and gynecology. 2006; 195(2):601–6. Epub 2006/06/27. doi: 10.1016/j.ajog.2006.04.012. PMID:
16796980.
23. Chervenak JL, Divon MY, Hirsch J, Girz BA, Langer O. Macrosomia in the postdate pregnancy: Is rou-
tine ultrasonographic screening indicated? American Journal of Obstetrics and Gynecology. 1989; 161
(3):753–6. https://doi.org/10.1016/0002-9378(89)90395-5 PMID: 2675605.
24. Cohen JM, Hutcheon JA, Kramer MS, Joseph KS, Abenhaim H, Platt RW. Influence of ultrasound-to-
delivery interval and maternal-fetal characteristics on validity of estimated fetal weight. Ultrasound in
obstetrics & gynecology: the official journal of the International Society of Ultrasound in Obstetrics and
Gynecology. 2010; 35(4):434–41. PMID: 359676712.
25. Crimmins S, Mo C, Nassar Y, Kopelman JN, Turan OM. Polyhydramnios or Excessive Fetal Growth
Are Markers for Abnormal Perinatal Outcome in Euglycemic Pregnancies. American Journal of Perina-
tology. 2018; 35(2):140–5. https://doi.org/10.1055/s-0037-1606186 PMID: 28838004.
PLOS MEDICINE Third-trimester screening for macrosomia
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003190 October 13, 2020 13 / 15
26. Cromi A, Ghezzi F, Di Naro E, Siesto G, Bergamini V, Raio L. Large cross-sectional area of the umbilical
cord as a predictor of fetal macrosomia. Ultrasound in Obstetrics & Gynecology. 2007; 30(6):861–6.
https://doi.org/10.1002/uog.5183 PMID: 17960667.
27. De Reu PAOM, Smits LJM, Oosterbaan HP, Nijhuis JG. Value of a single early third trimester fetal biom-
etry for the prediction of birth weight deviations in a low risk population. Journal of Perinatal Medicine.
2008; 36(4):324–9. https://doi.org/10.1515/JPM.2008.057 PMID: 18598122
28. Freire DMC, Cecatti JG, Paiva CSM. Correlation between estimated fetal weight by ultrasound and neo-
natal weight. [Portuguese]. Revista Brasileira de Ginecologia e Obstetricia. 2010; 32(1):4–10. https://
doi.org/10.1590/s0100-72032010000100002 PMID: 20209256.
29. Galvin DM, Burke N, Burke G, Breathnach F, McAuliffe F, Morrison J, et al. 94: Accuracy of prenatal
detection of macrosomia >4,000g and outcomes in the absence of intervention: results of the prospec-
tive multicenter genesis study. American Journal of Obstetrics and Gynecology. 2017; 216(1, Supple-
ment):S68. https://doi.org/10.1016/j.ajog.2016.11.983.
30. Gilby JR, Williams MC, Spellacy WN. Fetal abdominal circumference measurements of 35 and 38 cm
as predictors of macrosomia. A risk factor for shoulder dystocia. Journal of Reproductive Medicine.
2000; 45(11):936–8. PMID: 11127108.
31. Hasenoehrl G, Pohlhammer A, Gruber R, Staudach A, Steiner H. Fetal weight estimation by 2D and 3D
ultrasound: Comparison of six formulas. Ultraschall in der Medizin. 2009; 30(6):585–90. https://doi.org/
10.1055/s-0028-1109185 PMID: 19544232.
32. Hendrix NW, Grady CS, Chauhan SP. Clinical vs. sonographic estimate of birth weight in term parturi-
ents. A randomized clinical trial. Journal of Reproductive Medicine. 2000; 45(4):317–22. PMID:
10804488.
33. Henrichs C, Magann EF, Brantley KL, Crews JH, Sanderson M, Chauhan SP. Detecting fetal macroso-
mia with abdominal circumference alone. Journal of Reproductive Medicine. 2003; 48(5):339–42.
PMID: 12815906.
34. Humphries J, Reynolds D, Bell-Scarbrough L, Lynn N, Scardo JA, Chauhan SP. Sonographic estimate
of birth weight: relative accuracy of sonographers versus maternal-fetal medicine specialists. Journal of
Maternal-Fetal & Neonatal Medicine. 2002; 11(2):108–12. https://doi.org/10.1080/jmf.11.2.108.112
PMID: 12375539.
35. Kayem G, Grange G, Breart G, Goffinet F. Comparison of fundal height measurement and sonographi-
cally measured fetal abdominal circumference in the prediction of high and low birth weight at term.
Ultrasound in obstetrics & gynecology: the official journal of the International Society of Ultrasound in
Obstetrics and Gynecology. 2009; 34(5):566–71. Epub 2009/07/08. doi: 10.1002/uog.6378. PMID:
19582801.
36. Kehl S, Brade J, Schmidt U, Berlit S, Bohlmann MK, Sutterlin M, et al. Role of fetal abdominal circumfer-
ence as a prognostic parameter of perinatal complications. Archives of Gynecology & Obstetrics. 2011;
284(6):1345–9. https://doi.org/10.1007/s00404-011-1888-8 PMID: 21431328.
37. Khan N, Ciobanu A, Karampitsakos T, Akolekar R, Nicolaides KH. Prediction of large for gestational
age neonates by routine third trimester ultrasound. Ultrasound in obstetrics & gynecology: the official
journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2019; 25. PMID:
628504046.
38. Levine AB, Lockwood CJ, Brown B, Lapinski R, Berkowitz RL. Sonographic diagnosis of the large for
gestational age fetus at term: does it make a difference? Obstetrics & Gynecology. 1992; 79(1):55–8.
PMID: 1727587.
39. Melamed N, Yogev Y, Meizner I, Mashiach R, Pardo J, Ben-Haroush A. Prediction of fetal macrosomia:
effect of sonographic fetal weight-estimation model and threshold used. Ultrasound in obstetrics &
gynecology: the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
2011; 38(1):74–81. PMID: 362515594.
40. Miller JM Jr., Korndorffer FA 3rd, Gabert HA. Fetal weight estimates in late pregnancy with emphasis on
macrosomia. Journal of Clinical Ultrasound. 1986; 14(6):437–42. https://doi.org/10.1002/jcu.
1870140606 PMID: 3091643.
41. Miller JM Jr, Brown HL, Khawli OF, Pastorek IJG, Gabert HA. Ultrasonographic identification of the
macrosomic fetus. American Journal of Obstetrics and Gynecology. 1988; 159(5):1110–4. https://doi.
org/10.1016/0002-9378(88)90423-1 PMID: 3055998.
42. Nahum GG, Pham KQ, McHugh JP. Ultrasonic prediction of term birth weight in Hispanic women. Accu-
racy in an outpatient clinic. Journal of Reproductive Medicine. 2003; 48(1):13–22. PMID: 12611089.
43. Nahum GG, Stanislaw H. A computerized method for accurately predicting fetal macrosomia up to 11
weeks before delivery. European Journal of Obstetrics, Gynecology, & Reproductive Biology. 2007;
133(2):148–56. https://doi.org/10.1016/j.ejogrb.2006.08.011 PMID: 17010500.
PLOS MEDICINE Third-trimester screening for macrosomia
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003190 October 13, 2020 14 / 15
44. Nicod AC, Hohlfeld P, Vial Y. Performance of ultrasound estimation of fetal weight in fetuses weighing <
= 2000 g and more than 4000 g. [French]. Revue Medicale Suisse. 2012; 8(359):2022–7. PMID:
23167077.
45. O’Reilly-Green CP, Divon MY. Receiver operating characteristic curves of sonographic estimated fetal
weight for prediction of macrosomia in prolonged pregnancies. Ultrasound in obstetrics & gynecology:
the official journal of the International Society of Ultrasound in Obstetrics and Gynecology. 1997; 9
(6):403–8. Epub 1997/06/01. doi: 10.1046/j.1469-0705.1997.09060403.x. PMID: 9239826.
46. Pates JA, McIntire DD, Casey BM, Leveno KJ. Predicting macrosomia. Journal of Ultrasound in Medi-
cine. 2008; 27(1):39–43. https://doi.org/10.7863/jum.2008.27.1.39 PMID: 18096729.
47. Peregrine E, O’Brien P, Jauniaux E. Clinical and ultrasound estimation of birth weight prior to induction
of labor at term. Ultrasound in Obstetrics & Gynecology. 2007; 29(3):304–9. https://doi.org/10.1002/
uog.3949 PMID: 17290365.
48. Pollack RN, Hauer-Pollack G, Divon MY. Macrosomia in postdates pregnancies: the accuracy of routine
ultrasonographic screening. American Journal of Obstetrics & Gynecology. 1992; 167(1):7–11. https://
doi.org/10.1016/s0002-9378(11)91615-9 PMID: 1442959.
49. Rossavik IK, Joslin GL. Macrosomatia and ultrasonography: what is the problem? Southern Medical
Journal. 1993; 86(10):1129–32. https://doi.org/10.1097/00007611-199310000-00010 PMID: 8211330.
50. Sapir A, Khayyat I, Drukker L, Rabinowitz R, Samueloff A, Sela HY. Ultrasound predication of shoulder
dystocia in low risk term singleton deliveries. American Journal of Obstetrics and Gynecology. 2017;
216 (1 Supplement 1):S221. PMID: 614090070.
51. Smith GC, Smith MF, McNay MB, Fleming JE. The relation between fetal abdominal circumference and
birthweight: findings in 3512 pregnancies. British journal of obstetrics and gynaecology. 1997; 104
(2):186–90. Epub 1997/02/01. https://doi.org/10.1111/j.1471-0528.1997.tb11042.x PMID: 9070136.
52. Sovio U, Moraitis AA, Wong HS, Smith GCS. Universal vs selective ultrasonography to screen for large-
for-gestational-age infants and associated morbidity. Ultrasound in obstetrics & gynecology: the official
journal of the International Society of Ultrasound in Obstetrics and Gynecology. 2018; 51(6):783–91.
Epub 2017/04/21. doi: 10.1002/uog.17491. PMID: 28425156.
53. Sritippayawan S, Anansakunwat W, Suthantikorn C. The accuracy of gestation-adjusted projection
method in estimating birth weight by sonographic fetal measurements in the third trimester. Journal of
the Medical Association of Thailand. 2007; 90(6):1058–67. PMID: 17624197.
54. Sylvestre G, Divon MY, Onyeije C, Fisher M. Diagnosis of macrosomia in the postdates population:
combining sonographic estimates of fetal weight with glucose challenge testing. Journal of Maternal-
Fetal Medicine. 2000; 9(5):287–90. https://doi.org/10.1002/1520-6661(200009/10)9:5<287::AID-
MFM6>3.0.CO;2-1 PMID: 11132584.
55. Weiner Z, Ben-Shlomo I, Beck-Fruchter R, Goldberg Y, Shalev E. Clinical and ultrasonographic weight
estimation in large for gestational age fetus. European Journal of Obstetrics, Gynecology, & Reproduc-
tive Biology. 2002; 105(1):20–4. https://doi.org/10.1016/s0301-2115(02)00140-9 PMID: 12270559.
56. Burke N, Burke G, Breathnach F, McAuliffe F, Morrison JJ, Turner M, et al. Prediction of cesarean deliv-
ery in the term nulliparous woman: results from the prospective, multicenter Genesis study. American
journal of obstetrics and gynecology. 2017; 216(6):598.e1–.e11. Epub 2017/02/19. doi: 10.1016/j.ajog.
2017.02.017. PMID: 28213060.
57. Ouzounian JG. Shoulder Dystocia: Incidence and Risk Factors. Clin Obstet Gynecol. 2016; 59(4):791–
4. Epub 2016/10/21. doi: 10.1097/GRF.0000000000000227. PMID: 27662540.
58. Little SE, Edlow AG, Thomas AM, Smith NA. Estimated fetal weight by ultrasound: a modifiable risk fac-
tor for cesarean delivery? American journal of obstetrics and gynecology. 2012; 207(4):309.e1–6. Epub
2012/08/21. doi: 10.1016/j.ajog.2012.06.065. PMID: 22902073.
59. Blackwell SC, Refuerzo J, Chadha R, Carreno CA. Overestimation of fetal weight by ultrasound: does it
influence the likelihood of cesarean delivery for labor arrest? American journal of obstetrics and gyne-
cology. 2009; 200(3):340.e1–3. Epub 2009/03/04. doi: 10.1016/j.ajog.2008.12.043. PMID: 19254597.
60. Sovio U, White IR, Dacey A, Pasupathy D, Smith GCS. Screening for fetal growth restriction with univer-
sal third trimester ultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP)
study: a prospective cohort study. Lancet (London, England). 2015; 386(10008):2089–97. Epub 2015/
09/12. doi: 10.1016/s0140-6736(15)00131-2. PMID: 26360240; PubMed Central PMCID:
PMC4655320.
61. Heazell AE, Hayes DJ, Whitworth M, Takwoingi Y, Bayliss SE, Davenport C. Biochemical tests of pla-
cental function versus ultrasound assessment of fetal size for stillbirth and small-for-gestational-age
infants. Cochrane Database Syst Rev. 2019; 5:Cd012245. Epub 2019/05/16. doi: 10.1002/14651858.
CD012245.pub2. PMID: 31087568; PubMed Central PMCID: PMC6515632.
PLOS MEDICINE Third-trimester screening for macrosomia
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003190 October 13, 2020 15 / 15
